Lithium chloride hydrate

1 1

Selleck Chemicals

E7640

€0,00 EUR
€0,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

Lithium chloride hydrate is an inhibitor linked to PI3K-Akt-mTOR Signaling and related pathway-oriented research. It is especially relevant in infectious disease models, where defined compound exposure can be linked to growth-factor signaling, survival control, and nutrient-sensing outputs.

The pathway annotation connects Lithium chloride hydrate to PI3K-Akt-mTOR Signaling, supporting experiments that monitor growth-factor signaling, survival control, and nutrient-sensing outputs across biochemical, cellular, or phenotypic assay formats. This context is compatible with AKT/mTOR readouts, pathway-response, and viability assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In infectious disease models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in infectious disease models
  • Combination studies with orthogonal perturbagens

Overall, Lithium chloride hydrate is well suited to pathway-oriented studies that need a defined compound input for PI3K-Akt-mTOR Signaling readouts in infectious disease models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
PI3K-Akt-mTOR Signaling
Research Area:
Infectious Disease
CAS No.:
85144-11-2
Molecular Weight:
42.39 (anhydrous basis)
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.